FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--May. 30, 2013--
MEDNAX, Inc., (NYSE:MD) today announced the acquisition of Anesthesia
Specialists of Houston, L.L.P., a physician group practice based in
Houston, Texas. The practice will become part of MEDNAX’s American
Anesthesiology division and is the third Texas-based anesthesiology
practice to join this division.
Anesthesia Specialists of Houston has been serving the Greater Houston
metropolitan area since 1981 and is a private group practice consisting
of 9 anesthesiologists, 30 anesthetists and 9 other clinical and
administrative support staff. The practice provides anesthesia services
at The Woman's Hospital of Texas, which is dedicated solely to the
health of women and newborns, as well as at Fannin Surgicare, an
outpatient ambulatory surgical center.
MEDNAX’s Pediatrix Medical Group division currently provides neonatal
intensive care services at The Woman's Hospital of Texas.
“We wanted to be part of American Anesthesiology for reasons that go
beyond the many challenges we face in the future of healthcare,” said
Hector Santiago, M.D., who will serve as medical director for the
practice. “Not only does MEDNAX already have an excellent relationship
with The Woman’s Hospital of Texas through their NICU, but the company’s
unparalleled experience and resources, and the fact that its physicians
and leadership place a high value on clinical research, education and
quality is what convinced us that we found the right partner.”
MEDNAX’s American Anesthesiology division consists of more than 1,600
anesthesia providers, including more than 650 physicians and 950
anesthetists practicing in North Carolina, Florida, Georgia, Michigan,
New Jersey, Tennessee, Texas, and Virginia.
This practice was acquired for cash and the transaction is expected to
be immediately accretive to earnings. No additional terms of the
transaction were disclosed.
ABOUT MEDNAX
MEDNAX, Inc. is a national medical group that comprises the nation's
leading provider of neonatal, maternal-fetal and pediatric physician
subspecialty services as well as anesthesia services. Physicians and
advanced practitioners practicing as part of MEDNAX are reshaping the
delivery of care within their specialties and subspecialties, using
evidence-based tools, continuous quality initiatives and clinical
research to enhance patient outcomes and provide high-quality,
cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was
founded in 1979 and now includes neonatal physicians who provide
services at more than 330 neonatal intensive care units, who collaborate
with affiliated maternal-fetal medicine, pediatric cardiology and
pediatric critical care physician subspecialists to provide a clinical
care continuum. Pediatrix is also the nation's largest provider of
newborn hearing screens. In 2007, MEDNAX expanded into anesthesia
services. Today, American Anesthesiology includes more than 1,600
anesthesiologists and advanced practitioners who provide anesthesia care
to patients in connection with surgical and other procedures as well as
pain management. MEDNAX, through its affiliated professional
corporations, employs more than 2,150 physicians in 34 states and Puerto
Rico. Additional information is available at www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”,
“will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
MEDNAX undertakes no duty to update or revise any such statements,
whether as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance and
are subject to risks and uncertainties. Important factors that could cause
actual results, developments, and business decisions to differ
materially from forward-looking statements are described in MEDNAX’s
most recent Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s
current reports on Form 8-K, filed with the Securities and
Exchange Commission.
Source: MEDNAX, Inc.
MEDNAX, Inc.
David T. Parker, 954-384-0175, Ext. 5300
Vice
President, Investor Relations & Corporate Communications
david_parker@mednax.com